|
Study Finds FDA, CMS Regularly Miss Mandatory Review Timelines
The FDA and Centers for Medicare and Medicaid Services (CMS) continue to struggle — and often fail — to meet statutory deadlines for approving Class III devices and issuing national coverage decisions (NCD), according to a paper in the October issue of Health Affairs that looked at median approval times since the mid-1990s.
This article is viewable by subscribers only. To view this article, please select an option below.
|
|
Subscribe
Archives